(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of MYD88 mRNA CTD PMID:17971868 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1551097 6480464 epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of MYD88 protein] CTD PMID:27890776 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1345144 6480464 epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of MYD88 protein] CTD PMID:27890776 1,2-dimethylhydrazine multiple interactions ISO RGD:1551097 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYD88 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551097 6480464 Tetrachlorodibenzodioxin results in increased expression of MYD88 mRNA CTD PMID:14718646 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MYD88 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551097 6480464 Tetrachlorodibenzodioxin affects the expression of MYD88 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MYD88 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551097 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MYD88 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MYD88 promoter] CTD PMID:19654925 , PMID:25975270 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein] CTD PMID:19002562 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of MYD88, Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein CTD PMID:16891783 , PMID:19002562 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of MYD88 mRNA CTD PMID:21346803 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine multiple interactions EXP 6480464 gastrodin inhibits the reaction [4-iodo-2 more ... CTD PMID:30790395 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine increases expression EXP 6480464 4-iodo-2, 5-dimethoxyphenylisopropylamine results in increased expression of MYD88 protein CTD PMID:30790395 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine increases expression ISO RGD:1345144 6480464 Platelet Activating Factor results in increased expression of MYD88 protein CTD PMID:32830409 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine multiple interactions ISO RGD:1345144 6480464 PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased expression of MYD88 protein] CTD PMID:32830409 2-butoxyethanol increases expression ISO RGD:1551097 6480464 n-butoxyethanol results in increased expression of MYD88 mRNA CTD PMID:19812364 3-mercaptopropanoic acid multiple interactions ISO RGD:1551097 6480464 [3-Mercaptopropionic Acid co-treated with cadmium telluride] results in increased expression of MYD88 protein CTD PMID:29852215 3-phenylprop-2-enal multiple interactions ISO RGD:1551097 6480464 cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA], cinnamaldehyde inhibits the reaction [Poly I-C results in increased expression of MYD88 mRNA] CTD PMID:18306459 4-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-6-oxo-7H-thieno[2,3-b]pyridine-5-carbonitrile multiple interactions ISO RGD:1551097 6480464 [4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:28096963 4-hydroxyphenyl retinamide increases expression ISO RGD:1551097 6480464 Fenretinide results in increased expression of MYD88 mRNA CTD PMID:28973697 4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic acid methyl ester multiple interactions ISO RGD:1551097 6480464 Carticaine inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] CTD PMID:32687258 aflatoxin B1 increases expression ISO RGD:1551097 6480464 Aflatoxin B1 results in increased expression of MYD88 mRNA CTD PMID:28789997 aflatoxin B2 decreases methylation ISO RGD:1345144 6480464 aflatoxin B2 results in decreased methylation of MYD88 promoter CTD PMID:30157460 aldehydo-D-glucose multiple interactions EXP 6480464 artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] CTD PMID:30031708 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of MYD88 protein CTD PMID:30031708 all-trans-retinoic acid increases expression ISO RGD:1345144 6480464 Tretinoin results in increased expression of MYD88 mRNA CTD PMID:15498508 alpha-D-galactose multiple interactions ISO RGD:1551097 6480464 [Galactose co-treated with lipopolysaccharide more ... CTD PMID:23535186 antirheumatic drug decreases expression ISO RGD:1345144 6480464 Antirheumatic Agents results in decreased expression of MYD88 mRNA CTD PMID:24449571 aristolochic acid increases expression ISO RGD:1345144 6480464 aristolochic acid I results in increased expression of MYD88 mRNA, aristolochic acid I results in increased expression of MYD88 protein CTD PMID:33212167 arsane decreases expression ISO RGD:1551097 6480464 Arsenic results in decreased expression of MYD88 mRNA, Arsenic results in decreased expression of MYD88 protein CTD PMID:19654921 arsenic atom decreases expression ISO RGD:1551097 6480464 Arsenic results in decreased expression of MYD88 mRNA, Arsenic results in decreased expression of MYD88 protein CTD PMID:19654921 arsenite(3-) multiple interactions ISO RGD:1551097 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of MYD88 mRNA] CTD PMID:18929588 arsenite(3-) decreases expression ISO RGD:1551097 6480464 arsenite results in decreased expression of MYD88 mRNA CTD PMID:18929588 arsenous acid increases expression ISO RGD:1345144 6480464 Arsenic Trioxide results in increased expression of MYD88 mRNA CTD PMID:17530438 artesunate multiple interactions EXP 6480464 artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] CTD PMID:30031708 baicalin decreases expression EXP 6480464 baicalin results in decreased expression of MYD88 protein CTD PMID:22019745 benzene increases expression ISO RGD:1345144 6480464 Benzene results in increased expression of MYD88 mRNA CTD PMID:19162166 , PMID:33064461 benzo[a]pyrene increases methylation ISO RGD:1551097 6480464 Benzo(a)pyrene results in increased methylation of MYD88 3' UTR more ... CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:1345144 6480464 benzo(e)pyrene results in decreased methylation of MYD88 promoter CTD PMID:30157460 beta-D-glucan multiple interactions ISO RGD:1551097 6480464 MYD88 gene mutant form inhibits the reaction [beta-Glucans results in increased secretion of IL6 protein], MYD88 gene mutant form inhibits the reaction [beta-Glucans results in increased secretion of TNF protein] CTD PMID:17572156 bis(2-chloroethyl) sulfide increases expression ISO RGD:1551097 6480464 Mustard Gas results in increased expression of MYD88 mRNA CTD PMID:18955075 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MYD88 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of MYD88 mRNA CTD PMID:31129395 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MYD88 gene CTD PMID:28505145 bortezomib decreases expression ISO RGD:1345144 6480464 Bortezomib results in decreased expression of MYD88 mRNA CTD PMID:20471514 buspirone increases expression EXP 6480464 Buspirone results in increased expression of MYD88 mRNA CTD PMID:24136188 cadmium selenide multiple interactions ISO RGD:1345144 6480464 [cadmium selenide co-treated with zinc sulfide] results in increased expression of MYD88 mRNA CTD PMID:22342292 carbamazepine affects expression ISO RGD:1345144 6480464 Carbamazepine affects the expression of MYD88 mRNA CTD PMID:25979313 carbon atom multiple interactions ISO RGD:1345144 6480464 [Air Pollutants results in increased abundance of [Carbon co-treated with Particulate Matter]] which results in increased expression of MYD88 mRNA more ... CTD PMID:31268311 carbon nanotube increases expression ISO RGD:1551097 6480464 Nanotubes more ... CTD PMID:22293422 more ... carbon nanotube affects expression ISO RGD:1551097 6480464 Nanotubes, Carbon affects the expression of MYD88 mRNA CTD PMID:23845593 carmustine decreases expression ISO RGD:1345144 6480464 Carmustine results in decreased expression of MYD88 mRNA CTD PMID:15980968 casticin increases expression ISO RGD:1345144 6480464 casticin results in increased expression of MYD88 mRNA CTD PMID:27862857 chaetoglobosin A multiple interactions ISO RGD:1551097 6480464 chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA] CTD PMID:33285210 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 mRNA], Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 protein] CTD PMID:23146752 chlorogenic acid multiple interactions ISO RGD:1551097 6480464 Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of MYD88 protein] CTD PMID:26079055 chloroquine multiple interactions ISO RGD:1551097 6480464 Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MYD88 mRNA] CTD PMID:22341560 chrysin multiple interactions ISO RGD:1345144 6480464 chrysin inhibits the reaction [nickel chloride results in increased expression of MYD88 mRNA], chrysin inhibits the reaction [nickel chloride results in increased expression of MYD88 protein] CTD PMID:30016632 cisplatin multiple interactions ISO RGD:1345144 6480464 [Cisplatin co-treated with CDKN1A protein] results in increased expression of MYD88 mRNA CTD PMID:18483502 cisplatin multiple interactions EXP 6480464 crocin inhibits the reaction [Cisplatin results in increased expression of MYD88 mRNA], crocin inhibits the reaction [Cisplatin results in increased expression of MYD88 protein] CTD PMID:32259551 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MYD88 mRNA, Cisplatin results in increased expression of MYD88 protein CTD PMID:32259551 cisplatin increases expression ISO RGD:1551097 6480464 Cisplatin results in increased expression of MYD88 mRNA CTD PMID:26546572 clofibrate decreases expression ISO RGD:1551097 6480464 Clofibrate results in decreased expression of MYD88 mRNA CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of MYD88 mRNA CTD PMID:17602206 copper(II) sulfate decreases expression ISO RGD:1345144 6480464 Copper Sulfate results in decreased expression of MYD88 mRNA CTD PMID:19549813 crocin-1 multiple interactions EXP 6480464 crocin inhibits the reaction [Cisplatin results in increased expression of MYD88 mRNA], crocin inhibits the reaction [Cisplatin results in increased expression of MYD88 protein] CTD PMID:32259551 cudratricusxanthone A multiple interactions ISO RGD:1551097 6480464 cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] CTD PMID:31350693 curcumin multiple interactions ISO RGD:1345144 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA] CTD PMID:23452621 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein] CTD PMID:19002562 cyclosporin A increases expression ISO RGD:1551097 6480464 Cyclosporine results in increased expression of MYD88 mRNA CTD PMID:19770486 , PMID:27585667 cyclosporin A multiple interactions ISO RGD:1551097 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of MYD88 mRNA] CTD PMID:27585667 cyclosporin A decreases methylation ISO RGD:1345144 6480464 Cyclosporine results in decreased methylation of MYD88 promoter CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1345144 6480464 Cyclosporine results in decreased expression of MYD88 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose increases expression EXP 6480464 Glucose results in increased expression of MYD88 protein CTD PMID:30031708 D-glucose multiple interactions EXP 6480464 artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] CTD PMID:30031708 DAPT multiple interactions ISO RGD:1551097 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 protein] CTD PMID:24223152 DAPT multiple interactions EXP 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA] CTD PMID:24223152 deoxynivalenol multiple interactions ISO RGD:1551097 6480464 deoxynivalenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MYD88 protein] CTD PMID:26961612 dexamethasone multiple interactions ISO RGD:1551097 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] CTD PMID:32687258 diallyl trisulfide multiple interactions ISO RGD:1551097 6480464 diallyl trisulfide inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] CTD PMID:25500681 diarsenic trioxide increases expression ISO RGD:1345144 6480464 Arsenic Trioxide results in increased expression of MYD88 mRNA CTD PMID:17530438 diazinon increases methylation ISO RGD:1345144 6480464 Diazinon results in increased methylation of MYD88 gene CTD PMID:22964155 diclofenac increases expression ISO RGD:1551097 6480464 Diclofenac results in increased expression of MYD88 mRNA CTD PMID:26934552 dioxygen multiple interactions ISO RGD:1551097 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYD88 mRNA more ... CTD PMID:24223152 , PMID:30529165 dioxygen multiple interactions ISO RGD:1345144 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO RGD:1345144 6480464 Oxygen deficiency results in increased expression of MYD88 mRNA CTD PMID:23452621 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of MYD88 mRNA, Oxygen deficiency results in increased expression of MYD88 protein CTD PMID:24223152 , PMID:31629700 dioxygen increases expression ISO RGD:1551097 6480464 Oxygen deficiency results in increased expression of MYD88 protein CTD PMID:24223152 dioxygen multiple interactions EXP 6480464 N-(N-(3 more ... CTD PMID:24223152 , PMID:31629700 dorsomorphin multiple interactions ISO RGD:1551097 6480464 dorsomorphin inhibits the reaction [[4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2, 3-b)pyridine-5-carbonitrile co-treated with Lipopolysaccharides] results in increased expression of MYD88 protein] CTD PMID:28096963 doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with Fungal Polysaccharides] results in decreased expression of MYD88 mRNA CTD PMID:27181935 doxorubicin increases expression ISO RGD:1345144 6480464 Doxorubicin results in increased expression of MYD88 protein CTD PMID:29959987 doxorubicin decreases expression ISO RGD:1345144 6480464 Doxorubicin results in decreased expression of MYD88 mRNA CTD PMID:29803840 elemental carbon multiple interactions ISO RGD:1345144 6480464 [Air Pollutants results in increased abundance of [Carbon co-treated with Particulate Matter]] which results in increased expression of MYD88 mRNA more ... CTD PMID:31268311 erlotinib hydrochloride multiple interactions ISO RGD:1345144 6480464 [Erlotinib Hydrochloride results in decreased susceptibility to Erlotinib Hydrochloride] which affects the expression of MYD88 mRNA CTD PMID:27738319 esculetin multiple interactions ISO RGD:1551097 6480464 esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of MYD88 mRNA] CTD PMID:27769711 ethanol multiple interactions ISO RGD:1551097 6480464 Fructose promotes the reaction [Ethanol results in increased expression of MYD88 mRNA] CTD PMID:26858005 ethanol increases expression ISO RGD:1551097 6480464 Ethanol results in increased expression of MYD88 mRNA CTD PMID:26858005 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MYD88 mRNA, Ethanol results in increased expression of MYD88 protein CTD PMID:22525864 more ... ethanol multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Ethanol results in increased expression of MYD88 protein] more ... CTD PMID:22525864 more ... fisetin multiple interactions ISO RGD:1551097 6480464 fisetin inhibits the reaction [Lead results in increased expression of MYD88 protein] CTD PMID:31539617 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of MYD88 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1551097 6480464 [1 more ... CTD PMID:22206623 , PMID:24177262 folic acid decreases expression ISO RGD:1551097 6480464 Folic Acid results in decreased expression of MYD88 mRNA CTD PMID:25629700 fructose multiple interactions ISO RGD:1551097 6480464 Fructose promotes the reaction [Ethanol results in increased expression of MYD88 mRNA] CTD PMID:26858005 galactose multiple interactions ISO RGD:1551097 6480464 [Galactose co-treated with lipopolysaccharide more ... CTD PMID:23535186 Gastrodin multiple interactions EXP 6480464 gastrodin inhibits the reaction [4-iodo-2, 5-dimethoxyphenylisopropylamine results in increased expression of MYD88 protein] CTD PMID:30790395 Genipin multiple interactions ISO RGD:1551097 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA] CTD PMID:22687549 genistein multiple interactions ISO RGD:1345144 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA] CTD PMID:23452621 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MYD88 mRNA CTD PMID:22061828 Ginkgolide A multiple interactions ISO RGD:1551097 6480464 ginkgolide A inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 protein] CTD PMID:31697926 glucose increases expression EXP 6480464 Glucose results in increased expression of MYD88 protein CTD PMID:30031708 glucose multiple interactions EXP 6480464 artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] CTD PMID:30031708 graphene oxide increases expression ISO RGD:1551097 6480464 graphene oxide results in increased expression of MYD88 mRNA CTD PMID:33227293 high-density lipoprotein cholesterol multiple interactions ISO RGD:1345144 6480464 Cholesterol, HDL inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA] CTD PMID:20972769 hydrogen peroxide multiple interactions ISO RGD:1345144 6480464 Hydrogen Peroxide promotes the reaction [TRAF6 protein binds to [IL1R1 protein binds to MYD88 protein]] CTD PMID:16354686 icosanoid multiple interactions ISO RGD:1551097 6480464 MYD88 protein promotes the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids] CTD PMID:17369491 immunological adjuvant multiple interactions ISO RGD:1551097 6480464 MYD88 protein affects the reaction [[K-12 lipopolysaccharide co-treated with Adjuvants more ... CTD PMID:17404311 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of MYD88 mRNA CTD PMID:24842192 isoprenaline multiple interactions EXP 6480464 Metformin inhibits the reaction [Isoproterenol results in increased expression of MYD88 mRNA] CTD PMID:24842192 ivermectin decreases expression ISO RGD:1345144 6480464 Ivermectin results in decreased expression of MYD88 protein CTD PMID:32959892 lactulose multiple interactions EXP 6480464 Lactulose inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein] CTD PMID:30450033 lead(0) affects expression ISO RGD:1345144 6480464 Lead affects the expression of MYD88 mRNA CTD PMID:28903495 lead(0) increases expression ISO RGD:1551097 6480464 Lead results in increased expression of MYD88 protein CTD PMID:31539617 lead(0) multiple interactions ISO RGD:1551097 6480464 fisetin inhibits the reaction [Lead results in increased expression of MYD88 protein] CTD PMID:31539617 lead(2+) affects expression ISO RGD:1345144 6480464 Lead affects the expression of MYD88 mRNA CTD PMID:28903495 lead(2+) increases expression ISO RGD:1551097 6480464 Lead results in increased expression of MYD88 protein CTD PMID:31539617 lead(2+) multiple interactions ISO RGD:1551097 6480464 fisetin inhibits the reaction [Lead results in increased expression of MYD88 protein] CTD PMID:31539617 lipopolysaccharide increases expression ISO RGD:1345144 6480464 Lipopolysaccharides results in increased expression of MYD88 mRNA, Lipopolysaccharides results in increased expression of MYD88 protein CTD PMID:20972769 more ... lipopolysaccharide increases expression ISO RGD:1551097 6480464 Lipopolysaccharides results in increased expression of MYD88 more ... CTD PMID:15593098 more ... lipopolysaccharide decreases expression ISO RGD:1551097 6480464 Lipopolysaccharides results in decreased expression of MYD88 mRNA CTD PMID:25896969 lipopolysaccharide increases response to substance EXP 6480464 MYD88 protein results in increased susceptibility to Lipopolysaccharides CTD PMID:20865294 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Titanium] results in decreased expression of MYD88 mRNA CTD PMID:21308757 lipopolysaccharide multiple interactions ISO RGD:1551097 6480464 [4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:16892068 more ... lipopolysaccharide multiple interactions ISO RGD:1345144 6480464 3-hydro-2 more ... CTD PMID:20972769 more ... melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [tetrachlorobenzoquinone results in increased expression of MYD88 mRNA] more ... CTD PMID:28238930 metam multiple interactions ISO RGD:1551097 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA] CTD PMID:24056979 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Isoproterenol results in increased expression of MYD88 mRNA] CTD PMID:24842192 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of MYD88 protein CTD PMID:30450033 methamphetamine increases expression ISO RGD:1551097 6480464 Methamphetamine results in increased expression of MYD88 protein CTD PMID:33359793 methamphetamine multiple interactions EXP 6480464 Lactulose inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein] CTD PMID:30450033 methapyrilene decreases methylation ISO RGD:1345144 6480464 Methapyrilene results in decreased methylation of MYD88 promoter CTD PMID:30157460 methotrexate increases expression ISO RGD:1345144 6480464 Methotrexate results in increased expression of MYD88 mRNA CTD PMID:21678067 methotrexate multiple interactions ISO RGD:1345144 6480464 [Methotrexate co-treated with CDKN1A protein] results in decreased expression of MYD88 mRNA CTD PMID:18483502 monocrotaline decreases response to substance ISO RGD:1551097 6480464 MYD88 gene mutant form results in decreased susceptibility to Monocrotaline CTD PMID:31504964 motexafin gadolinium multiple interactions ISO RGD:1345144 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of MYD88 mRNA CTD PMID:16357179 motexafin gadolinium decreases expression ISO RGD:1345144 6480464 motexafin gadolinium results in decreased expression of MYD88 mRNA CTD PMID:16357179 muramyl dipeptide increases response to substance ISO RGD:1551097 6480464 MYD88 protein results in increased susceptibility to Acetylmuramyl-Alanyl-Isoglutamine analog CTD PMID:15905553 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1345144 6480464 N more ... CTD PMID:17622302 N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide multiple interactions EXP 6480464 Tiapride Hydrochloride inhibits the reaction [4-iodo-2, 5-dimethoxyphenylisopropylamine results in increased expression of MYD88 protein] CTD PMID:30790395 N-acetyl-L-cysteine multiple interactions ISO RGD:1551097 6480464 [Particulate Matter co-treated with Acetylcysteine co-treated with Polymyxin B] results in increased secretion of MYD88 protein more ... CTD PMID:28495615 , PMID:28555929 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1551097 6480464 Ethylnitrosourea results in increased mutagenesis of MYD88 exon CTD PMID:16300676 N-methyl-4-phenylpyridinium increases expression ISO RGD:1551097 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MYD88 protein CTD PMID:31299241 N-nitrosodiethylamine multiple interactions ISO RGD:1551097 6480464 MYD88 protein affects the reaction [Diethylnitrosamine results in increased expression of IL6 protein], MYD88 protein promotes the reaction [Diethylnitrosamine results in increased expression of IL6 protein] CTD PMID:17615358 more ... N-nitrosodiethylamine increases response to substance ISO RGD:1551097 6480464 MYD88 protein results in increased susceptibility to Diethylnitrosamine CTD PMID:18093689 nickel atom increases expression ISO RGD:1345144 6480464 Nickel results in increased expression of MYD88 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression ISO RGD:1345144 6480464 nickel chloride results in increased expression of MYD88 mRNA, nickel chloride results in increased expression of MYD88 protein CTD PMID:21473897 , PMID:30016632 nickel dichloride multiple interactions ISO RGD:1345144 6480464 chrysin inhibits the reaction [nickel chloride results in increased expression of MYD88 mRNA] more ... CTD PMID:24080332 , PMID:30016632 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of MYD88 protein CTD PMID:30481583 o-anisidine decreases expression ISO RGD:1345144 6480464 2-anisidine results in decreased expression of MYD88 mRNA CTD PMID:28089782 ozone multiple interactions ISO RGD:1551097 6480464 MYD88 gene mutant form inhibits the reaction [Ozone results in increased expression of CXCL1 mRNA] more ... CTD PMID:17626835 ozone increases expression ISO RGD:1551097 6480464 Ozone results in increased expression of MYD88 mRNA CTD PMID:17626835 more ... ozone decreases response to substance ISO RGD:1551097 6480464 MYD88 gene mutant form results in decreased susceptibility to Ozone CTD PMID:17626835 paracetamol decreases expression ISO RGD:1345144 6480464 Acetaminophen results in decreased expression of MYD88 mRNA CTD PMID:21420995 more ... paracetamol multiple interactions ISO RGD:1551097 6480464 Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of MYD88 protein] CTD PMID:26079055 paracetamol increases expression ISO RGD:1551097 6480464 Acetaminophen results in increased expression of MYD88 protein CTD PMID:26079055 paracetamol affects response to substance ISO RGD:1345144 6480464 MYD88 gene polymorphism affects the susceptibility to Acetaminophen CTD PMID:26104854 paraquat multiple interactions ISO RGD:1551097 6480464 epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of MYD88 protein] more ... CTD PMID:27890776 more ... paraquat increases response to substance ISO RGD:1551097 6480464 MYD88 protein results in increased susceptibility to Paraquat CTD PMID:28131803 paraquat increases expression ISO RGD:1345144 6480464 Paraquat results in increased expression of MYD88 protein CTD PMID:27890776 paraquat increases expression ISO RGD:1551097 6480464 Paraquat results in increased expression of MYD88 mRNA, Paraquat results in increased expression of MYD88 protein CTD PMID:27890776 more ... paraquat multiple interactions ISO RGD:1345144 6480464 epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of MYD88 protein] CTD PMID:27890776 pentachlorophenol increases expression ISO RGD:1551097 6480464 Pentachlorophenol results in increased expression of MYD88 mRNA CTD PMID:23892564 pentobarbital increases expression EXP 6480464 Pentobarbital results in increased expression of MYD88 mRNA CTD PMID:16978161 peptidoglycan increases expression ISO RGD:1551097 6480464 Peptidoglycan results in increased expression of MYD88 protein CTD PMID:15593098 peptidoglycan multiple interactions ISO RGD:1551097 6480464 MYD88 gene mutant form inhibits the reaction [Peptidoglycan results in increased expression of IL10 protein] CTD PMID:17238832 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1345144 6480464 MYD88 mutant form inhibits the reaction [[Vitallium analog co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CXCL8 mRNA], MYD88 mutant form inhibits the reaction [[Vitallium analog co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CXCL8 protein] CTD PMID:23680697 pipoxolan multiple interactions ISO RGD:1551097 6480464 pipoxolan inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MYD88 protein] CTD PMID:32677756 pirinixic acid increases expression ISO RGD:1551097 6480464 pirinixic acid results in increased expression of MYD88 mRNA CTD PMID:18301758 , PMID:23811191 platycodin D multiple interactions EXP 6480464 platycodin D inhibits the reaction [Ethanol results in increased expression of MYD88 mRNA] CTD PMID:28852734 poly(I:C) multiple interactions ISO RGD:1551097 6480464 cinnamaldehyde inhibits the reaction [Poly I-C results in increased expression of MYD88 mRNA] CTD PMID:18306459 poly(I:C) increases expression ISO RGD:1551097 6480464 Poly I-C results in increased expression of MYD88 mRNA CTD PMID:18306459 polymyxin B2 multiple interactions ISO RGD:1551097 6480464 [Particulate Matter co-treated with Acetylcysteine co-treated with Polymyxin B] results in increased secretion of MYD88 protein more ... CTD PMID:28555929 progesterone increases expression ISO RGD:1551097 6480464 Progesterone results in increased expression of MYD88 mRNA CTD PMID:21549006 quercetin multiple interactions ISO RGD:1551097 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in increased phosphorylation of MYD88 protein] CTD PMID:23735482 quercetin multiple interactions ISO RGD:1345144 6480464 Quercetin inhibits the reaction [nickel chloride results in increased expression of MYD88 mRNA], Quercetin inhibits the reaction [nickel chloride results in increased expression of MYD88 protein] CTD PMID:30016632 quercetin decreases expression ISO RGD:1345144 6480464 Quercetin results in decreased expression of MYD88 mRNA CTD PMID:19729006 , PMID:21632981 resiquimod multiple interactions ISO RGD:1551097 6480464 MYD88 gene mutant form inhibits the reaction [resiquimod results in increased expression of IL10 protein] CTD PMID:17238832 resveratrol decreases expression ISO RGD:1551097 6480464 resveratrol results in decreased expression of MYD88 protein CTD PMID:24818579 resveratrol multiple interactions ISO RGD:1345144 6480464 resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA] CTD PMID:23452621 resveratrol decreases activity ISO RGD:1345144 6480464 resveratrol results in decreased activity of MYD88 protein CTD PMID:24617573 rosmarinic acid decreases expression EXP 6480464 rosmarinic acid results in decreased expression of MYD88 protein CTD PMID:28789951 rotenone decreases expression ISO RGD:1345144 6480464 Rotenone results in decreased expression of MYD88 mRNA CTD PMID:29955902 Salvianolic acid A multiple interactions ISO RGD:1551097 6480464 salvianolic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] CTD PMID:31654708 saxagliptin multiple interactions EXP 6480464 saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA] CTD PMID:31629700 Scoparone multiple interactions ISO RGD:1551097 6480464 scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of MYD88 protein] CTD PMID:23535186 scopoletin multiple interactions EXP 6480464 Scopoletin inhibits the reaction [Ethanol results in increased expression of MYD88 mRNA] CTD PMID:26115886 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of MYD88 mRNA CTD PMID:21602193 silicon dioxide multiple interactions ISO RGD:1551097 6480464 [MYD88 protein co-treated with TICAM1 protein] affects the susceptibility to Silicon Dioxide CTD PMID:18604214 silver atom affects expression ISO RGD:1345144 6480464 Silver affects the expression of MYD88 mRNA CTD PMID:22342292 silver(0) affects expression ISO RGD:1345144 6480464 Silver affects the expression of MYD88 mRNA CTD PMID:22342292 sodium arsenite decreases expression ISO RGD:1551097 6480464 sodium arsenite results in decreased expression of MYD88 mRNA CTD PMID:31233874 Soman increases expression EXP 6480464 Soman results in increased expression of MYD88 mRNA CTD PMID:19281266 streptozocin multiple interactions ISO RGD:1551097 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of MYD88 mRNA, esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of MYD88 mRNA] CTD PMID:27769711 sulfur dioxide multiple interactions ISO RGD:1345144 6480464 [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased expression of MYD88 mRNA CTD PMID:31268311 sunitinib decreases expression ISO RGD:1345144 6480464 Sunitinib results in decreased expression of MYD88 mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:1345144 6480464 tamibarotene results in increased expression of MYD88 mRNA CTD PMID:15498508 temozolomide increases expression ISO RGD:1345144 6480464 Temozolomide results in increased expression of MYD88 mRNA CTD PMID:31758290 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MYD88 mRNA, Carbon Tetrachloride results in increased expression of MYD88 protein CTD PMID:23146752 tetrachloromethane multiple interactions ISO RGD:1551097 6480464 ginkgolide A inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 protein] CTD PMID:31697926 tetrachloromethane increases expression ISO RGD:1551097 6480464 Carbon Tetrachloride results in increased expression of MYD88 protein CTD PMID:31697926 tetrachloromethane multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 mRNA], Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 protein] CTD PMID:23146752 thalidomide decreases expression ISO RGD:1551097 6480464 Thalidomide results in decreased expression of MYD88 mRNA CTD PMID:26006729 , PMID:26217789 titanium atom multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Titanium] results in decreased expression of MYD88 mRNA CTD PMID:21308757 titanium dioxide increases expression ISO RGD:1345144 6480464 titanium dioxide results in increased expression of MYD88 mRNA CTD PMID:22342292 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of MYD88 mRNA CTD PMID:31129395 trichostatin A affects expression ISO RGD:1345144 6480464 trichostatin A affects the expression of MYD88 mRNA CTD PMID:28542535 trimethyltin increases expression ISO RGD:1551097 6480464 trimethyltin results in increased expression of MYD88 mRNA CTD PMID:21435392 trovafloxacin multiple interactions ISO RGD:1551097 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MYD88 mRNA CTD PMID:18930950 urethane decreases expression ISO RGD:1345144 6480464 Urethane results in decreased expression of MYD88 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1345144 6480464 Valproic Acid results in decreased expression of MYD88 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1345144 6480464 Valproic Acid affects the expression of MYD88 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:1551097 6480464 Vancomycin results in decreased expression of MYD88 mRNA CTD PMID:18930951 zearalenone increases expression ISO RGD:1345144 6480464 Zearalenone results in increased expression of MYD88 mRNA CTD PMID:27757495 zinc acetate multiple interactions ISO RGD:1345144 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of MYD88 mRNA more ... CTD PMID:16357179 , PMID:24080332 zinc acetate decreases expression ISO RGD:1345144 6480464 Zinc Acetate results in decreased expression of MYD88 mRNA CTD PMID:16357179 zinc oxide multiple interactions ISO RGD:1551097 6480464 MYD88 mutant form inhibits the reaction [Zinc Oxide analog results in increased expression of CCL2 mRNA] more ... CTD PMID:23352990 , PMID:25127755 zinc protoporphyrin multiple interactions EXP 6480464 zinc protoporphyrin promotes the reaction [IRAK1 protein binds to MYD88 protein] more ... CTD PMID:25780291
